List of Tables
    Table 1. Mucopolysaccharidosis II CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Mucopolysaccharidosis II Market Trends
    Table 3. Mucopolysaccharidosis II Market Drivers
    Table 4. Mucopolysaccharidosis II Market Challenges
    Table 5. Mucopolysaccharidosis II Market Restraints
    Table 6. Global Mucopolysaccharidosis II Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Mucopolysaccharidosis II Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Mucopolysaccharidosis II Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Mucopolysaccharidosis II Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Mucopolysaccharidosis II Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Mucopolysaccharidosis II Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Mucopolysaccharidosis II Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Mucopolysaccharidosis II Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Mucopolysaccharidosis II Sales Share by Manufacturer, 2017-2022
    Table 15. Global Mucopolysaccharidosis II Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Mucopolysaccharidosis II Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Mucopolysaccharidosis II by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mucopolysaccharidosis II as of 2021)
    Table 18. Top Players of Mucopolysaccharidosis II in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Mucopolysaccharidosis II Product Type
    Table 20. Date of International Manufacturers Enter into Mucopolysaccharidosis II Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Mucopolysaccharidosis II Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Mucopolysaccharidosis II Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Mucopolysaccharidosis II Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Mucopolysaccharidosis II Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Mucopolysaccharidosis II Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Mucopolysaccharidosis II Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Mucopolysaccharidosis II Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Mucopolysaccharidosis II Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Mucopolysaccharidosis II Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Mucopolysaccharidosis II Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Mucopolysaccharidosis II Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Mucopolysaccharidosis II Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Mucopolysaccharidosis II Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Mucopolysaccharidosis II Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Mucopolysaccharidosis II Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Mucopolysaccharidosis II Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Mucopolysaccharidosis II Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Mucopolysaccharidosis II Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Mucopolysaccharidosis II Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Mucopolysaccharidosis II Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Alexion Pharmaceuticals, Inc. Corporation Information
    Table 43. Alexion Pharmaceuticals, Inc. Description and Business Overview
    Table 44. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product
    Table 46. Alexion Pharmaceuticals, Inc. Recent Development
    Table 47. AngioChem Inc. Corporation Information
    Table 48. AngioChem Inc. Description and Business Overview
    Table 49. AngioChem Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. AngioChem Inc. Product
    Table 51. AngioChem Inc. Recent Development
    Table 52. ArmaGen Inc. Corporation Information
    Table 53. ArmaGen Inc. Description and Business Overview
    Table 54. ArmaGen Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. ArmaGen Inc. Product
    Table 56. ArmaGen Inc. Recent Development
    Table 57. Bioasis Technologies Inc. Corporation Information
    Table 58. Bioasis Technologies Inc. Description and Business Overview
    Table 59. Bioasis Technologies Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Bioasis Technologies Inc. Product
    Table 61. Bioasis Technologies Inc. Recent Development
    Table 62. Green Cross Corporation Corporation Information
    Table 63. Green Cross Corporation Description and Business Overview
    Table 64. Green Cross Corporation Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Green Cross Corporation Product
    Table 66. Green Cross Corporation Recent Development
    Table 67. Inventiva Corporation Information
    Table 68. Inventiva Description and Business Overview
    Table 69. Inventiva Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. Inventiva Product
    Table 71. Inventiva Recent Development
    Table 72. JCR Pharmaceuticals Co., Ltd. Corporation Information
    Table 73. JCR Pharmaceuticals Co., Ltd. Description and Business Overview
    Table 74. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. JCR Pharmaceuticals Co., Ltd. Product
    Table 76. JCR Pharmaceuticals Co., Ltd. Recent Development
    Table 77. Laboratorios Del Dr. Esteve S.A. Corporation Information
    Table 78. Laboratorios Del Dr. Esteve S.A. Description and Business Overview
    Table 79. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. Laboratorios Del Dr. Esteve S.A. Product
    Table 81. Laboratorios Del Dr. Esteve S.A. Recent Development
    Table 82. RegenxBio Inc. Corporation Information
    Table 83. RegenxBio Inc. Description and Business Overview
    Table 84. RegenxBio Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. RegenxBio Inc. Product
    Table 86. RegenxBio Inc. Recent Development
    Table 87. Sangamo BioSciences, Inc. Corporation Information
    Table 88. Sangamo BioSciences, Inc. Description and Business Overview
    Table 89. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 90. Sangamo BioSciences, Inc. Product
    Table 91. Sangamo BioSciences, Inc. Recent Development
    Table 92. Takeda Corporation Information
    Table 93. Takeda Description and Business Overview
    Table 94. Takeda Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 95. Takeda Product
    Table 96. Takeda Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Mucopolysaccharidosis II Customers List
    Table 100. Mucopolysaccharidosis II Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Mucopolysaccharidosis II Product Picture
    Figure 2. Global Mucopolysaccharidosis II Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Mucopolysaccharidosis II Market Size 2017-2028 (US$ Million)
    Figure 4. Global Mucopolysaccharidosis II Sales 2017-2028 (K Pcs)
    Figure 5. United States Mucopolysaccharidosis II Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Mucopolysaccharidosis II Market Size 2017-2028 (US$ Million)
    Figure 7. United States Mucopolysaccharidosis II Sales 2017-2028 (K Pcs)
    Figure 8. United States Mucopolysaccharidosis II Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Mucopolysaccharidosis II Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Mucopolysaccharidosis II Report Years Considered
    Figure 11. Product Picture of JR-141
    Figure 12. Product Picture of EGT-301
    Figure 13. Product Picture of DUOC-01
    Figure 14. Product Picture of AGT-182
    Figure 15. Product Picture of JR-032
    Figure 16. Product Picture of Others
    Figure 17. Global Mucopolysaccharidosis II Market Share by Type in 2022 & 2028
    Figure 18. Global Mucopolysaccharidosis II Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 19. Global Mucopolysaccharidosis II Sales Market Share in Value by Type (2017-2028)
    Figure 20. Global Mucopolysaccharidosis II Sales by Type (2017-2028) & (K Pcs)
    Figure 21. Global Mucopolysaccharidosis II Sales Market Share in Volume by Type (2017-2028)
    Figure 22. Global Mucopolysaccharidosis II Price by Type (2017-2028) & (USD/Pcs)
    Figure 23. United States Mucopolysaccharidosis II Market Share by Type in 2022 & 2028
    Figure 24. United States Mucopolysaccharidosis II Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 25. United States Mucopolysaccharidosis II Sales Market Share in Value by Type (2017-2028)
    Figure 26. United States Mucopolysaccharidosis II Sales by Type (2017-2028) & (K Pcs)
    Figure 27. United States Mucopolysaccharidosis II Sales Market Share in Volume by Type (2017-2028)
    Figure 28. United States Mucopolysaccharidosis II Price by Type (2017-2028) & (USD/Pcs)
    Figure 29. Product Picture of Hospital
    Figure 30. Product Picture of Clinic
    Figure 31. Product Picture of Research Center
    Figure 32. Product Picture of Others
    Figure 33. Global Mucopolysaccharidosis II Market Share by Application in 2022 & 2028
    Figure 34. Global Mucopolysaccharidosis II Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. Global Mucopolysaccharidosis II Sales Market Share in Value by Application (2017-2028)
    Figure 36. Global Mucopolysaccharidosis II Sales by Application (2017-2028) & (K Pcs)
    Figure 37. Global Mucopolysaccharidosis II Sales Market Share in Volume by Application (2017-2028)
    Figure 38. Global Mucopolysaccharidosis II Price by Application (2017-2028) & (USD/Pcs)
    Figure 39. United States Mucopolysaccharidosis II Market Share by Application in 2022 & 2028
    Figure 40. United States Mucopolysaccharidosis II Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 41. United States Mucopolysaccharidosis II Sales Market Share in Value by Application (2017-2028)
    Figure 42. United States Mucopolysaccharidosis II Sales by Application (2017-2028) & (K Pcs)
    Figure 43. United States Mucopolysaccharidosis II Sales Market Share in Volume by Application (2017-2028)
    Figure 44. United States Mucopolysaccharidosis II Price by Application (2017-2028) & (USD/Pcs)
    Figure 45. North America Mucopolysaccharidosis II Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 46. North America Mucopolysaccharidosis II Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. U.S. Mucopolysaccharidosis II Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Canada Mucopolysaccharidosis II Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Europe Mucopolysaccharidosis II Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 50. Europe Mucopolysaccharidosis II Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 51. Germany Mucopolysaccharidosis II Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. France Mucopolysaccharidosis II Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. U.K. Mucopolysaccharidosis II Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Italy Mucopolysaccharidosis II Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Russia Mucopolysaccharidosis II Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Asia-Pacific Mucopolysaccharidosis II Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 57. Asia-Pacific Mucopolysaccharidosis II Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 58. China Mucopolysaccharidosis II Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Japan Mucopolysaccharidosis II Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. South Korea Mucopolysaccharidosis II Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. India Mucopolysaccharidosis II Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Australia Mucopolysaccharidosis II Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Taiwan Mucopolysaccharidosis II Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Indonesia Mucopolysaccharidosis II Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Thailand Mucopolysaccharidosis II Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Malaysia Mucopolysaccharidosis II Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Philippines Mucopolysaccharidosis II Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Latin America Mucopolysaccharidosis II Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 69. Latin America Mucopolysaccharidosis II Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Mexico Mucopolysaccharidosis II Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Brazil Mucopolysaccharidosis II Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Argentina Mucopolysaccharidosis II Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Middle East & Africa Mucopolysaccharidosis II Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 74. Middle East & Africa Mucopolysaccharidosis II Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 75. Turkey Mucopolysaccharidosis II Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Saudi Arabia Mucopolysaccharidosis II Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 77. U.A.E Mucopolysaccharidosis II Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 78. Mucopolysaccharidosis II Value Chain
    Figure 79. Mucopolysaccharidosis II Production Process
    Figure 80. Channels of Distribution
    Figure 81. Distributors Profiles
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed